Celsion Corp (CLSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Celsion Corp (CLSN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH1189D
  • |
  • Pages: 74
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company's three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of treatments for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp (CLSN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10

Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Celsion Corp, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Celsion Enters into Partnership with Children's Research Institute 13

Celsion Enters into Agreement with Zhejiang Hisun Pharma 14

Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15

Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16

Equity Offering 18

Celsion Plans to Raise up to USD75.5 Million in Public Offering of Securities 18

Celsion to Raise USD15 Million in Public Offering of Shares 19

Celsion to Raise up to USD10 Million in Public Offering of Shares 20

Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 21

Celsion Raises USD6.6 Million in Public Offering of Shares 22

Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 23

Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 24

Celsion to Raise up to USD2.4 Million in Public Offering of Shares 26

Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 27

Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 28

Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 29

Celsion Raises USD5 Million in Public Offering of Shares and Warrants 30

Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 31

Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 32

Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 33

Celsion Raises USD6 Million in Private Placement of Shares 34

Celsion Raises USD8 Million in Private Placement of Shares 35

Celsion Raises USD15 Million in Private Placement Of Common Stock 36

Celsion Raises USD9.8 Million in Private Placement of Shares 37

Celsion Completes Private Placement Of Shares For USD 15 Million 38

Celsion Completes Public Offering Of Common Stock For USD 7 Million 39

Acquisition 40

Celsion Completes Acquisition of Egen Biopharma Company 40

Celsion Explores Acquisition Opportunities 42

Celsion Corp-Key Competitors 43

Celsion Corp-Key Employees 44

Celsion Corp-Locations And Subsidiaries 45

Head Office 45

Recent Developments 46

Financial Announcements 46

Aug 14, 2018: Celsion announces second quarter 2018 financial results 46

May 11, 2018: Celsion Reports First Quarter 2018 Financial Results and Provides Business Update 49

Mar 27, 2018: Celsion Announces Fourth Quarter And Full-Year 2017 Financial Results 52

Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update 55

Aug 15, 2017: Celsion Reports Second Quarter 2017 Financial Results and Provides Business Update 58

May 12, 2017: Celsion Reports First Quarter 2017 Financial Results and Provides Business Update 61

Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update 63

Corporate Communications 65

Jun 25, 2018: Celsion to join Russell Microcap Index 65

Jun 14, 2018: Celsion regains compliance with NASDAQ listing requirements 66

Aug 04, 2017: Celsion to Delist from the Tel Aviv Stock Exchange 67

Other Significant Developments 68

Jul 11, 2018: Horizon Technology Finance provides investment portfolio update 68

Jan 18, 2018: Celsion Provides Corporate Update and 2018 Outlook 70

Appendix 74

Methodology 74

About GlobalData 74

Contact Us 74

Disclaimer 74

List of Figures

Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Celsion Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Celsion Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Celsion Corp, Medical Devices Deals, 2012 to YTD 2018 10

Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Celsion Enters into Partnership with Children's Research Institute 13

Celsion Enters into Agreement with Zhejiang Hisun Pharma 14

Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15

Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16

Celsion Plans to Raise up to USD75.5 Million in Public Offering of Securities 18

Celsion to Raise USD15 Million in Public Offering of Shares 19

Celsion to Raise up to USD10 Million in Public Offering of Shares 20

Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 21

Celsion Raises USD6.6 Million in Public Offering of Shares 22

Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 23

Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 24

Celsion to Raise up to USD2.4 Million in Public Offering of Shares 26

Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 27

Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 28

Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 29

Celsion Raises USD5 Million in Public Offering of Shares and Warrants 30

Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 31

Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 32

Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 33

Celsion Raises USD6 Million in Private Placement of Shares 34

Celsion Raises USD8 Million in Private Placement of Shares 35

Celsion Raises USD15 Million in Private Placement Of Common Stock 36

Celsion Raises USD9.8 Million in Private Placement of Shares 37

Celsion Completes Private Placement Of Shares For USD 15 Million 38

Celsion Completes Public Offering Of Common Stock For USD 7 Million 39

Celsion Completes Acquisition of Egen Biopharma Company 40

Celsion Explores Acquisition Opportunities 42

Celsion Corp, Key Competitors 43

Celsion Corp, Key Employees 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Celsion Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17250
Site License
USD 500 INR 34500
Corporate User License
USD 750 INR 51750

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com